28.21
Atricure Inc stock is traded at $28.21, with a volume of 646.90K.
It is up +2.10% in the last 24 hours and down -5.27% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$27.63
Open:
$27.73
24h Volume:
646.90K
Relative Volume:
0.95
Market Cap:
$1.43B
Revenue:
$534.53M
Net Income/Loss:
$-11.45M
P/E Ratio:
-117.01
EPS:
-0.2411
Net Cash Flow:
$48.28M
1W Performance:
-2.32%
1M Performance:
-5.27%
6M Performance:
-24.55%
1Y Performance:
-13.17%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ATRC
Atricure Inc
|
28.21 | 1.43B | 534.53M | -11.45M | 48.28M | -0.2411 |
|
ISRG
Intuitive Surgical Inc
|
478.82 | 169.58B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
154.85 | 44.05B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
46.23 | 39.09B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
75.86 | 36.98B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
219.51 | 31.98B | 5.40B | 1.49B | 1.78B | 10.12 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure (ATRC) Quarter End | Q4 2025: EPS Exceeds ExpectationsBusiness Risk - Xã Vĩnh Công
AtriCure stock hits 52-week low at 27.26 USD By Investing.com - Investing.com India
AtriCure stock hits 52-week low at 27.26 USD - Investing.com
A Look at AtriCure Inc (ATRC) After 3.1% Decline -- GF Value $41 - GuruFocus
Canaccord Genuity Maintains AtriCure (ATRC) Buy Recommendation - MSN
The Technical Signals Behind (ATRC) That Institutions Follow - Stock Traders Daily
Oak Harvest Investment Services Makes New $1.48 Million Investment in AtriCure, Inc. $ATRC - MarketBeat
AtriCure Inc (HAM:A5I) Stock Price, Trades & News - GuruFocus
AtriCure, Inc. Hits New 52-Week Low at $27.31 - Markets Mojo
AtriCure, Inc. $ATRC Shares Purchased by Massachusetts Financial Services Co. MA - MarketBeat
AtriCure to Announce First Quarter 2026 Financial Results - BioSpace
Bull Bear: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARFed Meeting & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Rep. Cisneros Buys AtriCure Shares - National Today
US Market Wrap: Why is AtriCure Inc stock going down2026 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
How is AtriCure (ATRC) Stock performing in 2026 | Price at $28.35, Up 1.07%Community Buy Alerts - Cổng thông tin điện tử tỉnh Lào Cai
US Market Wrap: Is AtriCure Inc a top pick in the sectorWeekly Investment Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Atricure stock hits 52-week low at $27.30 amid market challenges - Investing.com Australia
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure (NASDAQ:ATRC) Reaches New 12-Month LowTime to Sell? - MarketBeat
Shorts Report: What are AtriCure Incs recent SEC filings showing2026 Major Catalysts & Technical Pattern Recognition Alerts - baoquankhu1.vn
Assessing AtriCure (ATRC) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Aug Spikes: Why is AtriCure Inc stock going down2026 Price Targets & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Precision Trading with Atricure Inc. (ATRC) Risk Zones - Stock Traders Daily
Value Recap: Is AtriCure Inc a top pick in the sector2026 Volume & Scalable Portfolio Growth Methods - baoquankhu1.vn
AtriCure, Inc. ($ATRC) CEO 2025 Pay Revealed - Quiver Quantitative
AtriCure (NASDAQ: ATRC) 2026 proxy adds 2.25M shares to equity plans - Stock Titan
Is AtriCure (ATRC) Stock Breaking Support | Price at $29.32, Up 0.86%Volume Breakout - UBND thành phố Hải Phòng
Should AtriCure’s Q4 Revenue Beat and Cautious Analyst Tone Reshape the ATRC Investment Narrative? - Sahm
AtriCure (NASDAQ:ATRC) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ATRC Should I Buy - Intellectia AI
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Freedom Capital - MarketBeat
ATRC Stock Price, Quote & Chart | ATRICURE INC (NASDAQ:ATRC) - ChartMill
Freedom Capital Markets initiates Articure stock with buy rating By Investing.com - Investing.com India
Freedom Capital Markets initiates Articure stock with buy rating - Investing.com
ATRC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Valuation Update: What are AtriCure Incs recent SEC filings showingQuarterly Market Review & Stock Market Timing Techniques - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
AtriCure stock hits 52-week low at $28.25 amid market fluctuations By Investing.com - Investing.com South Africa
AtriCure stock hits 52-week low at $28.25 amid market fluctuations - Investing.com Australia
AtriCure Inc (ATRC) Stock Price Quote Today & Current Price Chart - Capital.com
AtriCure Inc (ATRC) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Resistance Check: Whats the fair value of AtriCure Inc stock2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
AtriCure Shares Plunge to New 1-Year Low - National Today
AtriCure (NASDAQ:ATRC) Hits New 1-Year LowHere's Why - MarketBeat
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):